Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

BACKGROUND: Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediterr J Hematol Infect Dis
Hauptverfasser: Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Università Cattolica del Sacro Cuore 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://ncbi.nlm.nih.gov/pubmed/32670518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.040
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge